2015
DOI: 10.1016/j.dmpk.2014.10.008
|View full text |Cite
|
Sign up to set email alerts
|

Effect of CAR polymorphism on the pharmacokinetics of artemisinin in healthy Chinese subjects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…It was proven that certain artemisinin drugs could induce the expression of CYP3A4/2B6 by activating hPXR or hCAR receptors in both human primary hepatocytes and LS174T cells [27]. Pharmacokinetic studies of Chinese healthy volunteers carrying different CAR genotypes revealed that the exposure of artemisinin and its metabolites in subjects with CAR variants (540C/T or 540T/T) was lower after multiple doses of oral administration [28]. Moreover, the study found that the activity of CYP3A4 varies from 30 to 90 % among different populations [29].…”
Section: Differential Effects Of Components In Artemisia Annua Extracmentioning
confidence: 99%
“…It was proven that certain artemisinin drugs could induce the expression of CYP3A4/2B6 by activating hPXR or hCAR receptors in both human primary hepatocytes and LS174T cells [27]. Pharmacokinetic studies of Chinese healthy volunteers carrying different CAR genotypes revealed that the exposure of artemisinin and its metabolites in subjects with CAR variants (540C/T or 540T/T) was lower after multiple doses of oral administration [28]. Moreover, the study found that the activity of CYP3A4 varies from 30 to 90 % among different populations [29].…”
Section: Differential Effects Of Components In Artemisia Annua Extracmentioning
confidence: 99%